Early Access — free while we kick the tires
EdgarHawk

LEWIN NICHOLAS SHERIDAN

Director

Director
2 filings analyzed · 1 company · Latest 2025-08-14

Companies

Company Buys Sells Direction
ESTABLISHMENT LABS HOLDINGS INC. ESTA 2 0 Net buying

Activity

August 2025
Buy
2,600 shares
$98,410
Significance 7/10

Director Lewin Nicholas Sheridan bought 2,600 shares of ESTA at $37.85 on 2025-08-14; holdings rise 15.8% to 19,090 shares

Director Lewin Nicholas Sheridan purchased 2,600 shares of Establishment Labs on 2025-08-14, representing a 15.8% increase in personal holdings to 19,090 shares. The insider's cross-ticker track record shows 5 prior open-market purchases averaging +15.4% return over 30 days and +48.6% over 90 days with a 75% win rate, establishing a pattern of well-timed accumulation. At the same ticker, his prior 4 measurable buys (2023–2024) delivered 90-day returns ranging from +81.8% to −60.7%, with 3 of 4 well-timed by the 90-day mark. However, this timing advantage applies to trades made over 1–2 years ago into a different market environment; the current purchase occurs at $37.85 following a −14.6% decline over the past 30 days and −22.2% from the 52-week high, while the company reported $-16.6M net loss on $51.3M revenue (latest quarter) with only +0.5% annual revenue growth. The accumulation signal is offset by deteriorating near-term price momentum and continued unprofitability, warranting attention to whether this reflects a positioned long-term conviction or entry during an extended drawdown.

Buy
2,300 shares
$78,880
Significance 6/10

Director Lewin Nicholas Sheridan bought 2,300 shares of ESTA at $34.30; stock down 15.8% in 30 days but insider's prior ESTA buys averaged +87.0% at 90d.

Director Lewin Nicholas Sheridan purchased 2,300 shares at $34.30, increasing holdings by 16.2% to 16,490 shares. The transaction occurred as the stock trades 21.4% below its 52-week high and down 15.8% over the past 30 days, positioning the buy near recent weakness. His prior trades at ESTA show strong long-term timing: three of four prior buys achieved gains of 31.6%, 31.1%, and 5.0% at the 30-day mark, with the first three buys all exceeding 81.8% returns at 90 days. However, the company remains unprofitable with negative net income of $16.6M on quarterly revenue of $51.3M and annual revenue growth of only +0.5%, which constrains the risk-reward profile despite the insider's historical execution at this security.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access